Graded exercise therapy

Graded exercise therapy has been studied in 3 papers since 2017: 2 trials in people. The newest paper, Aug 26, 2021: “Condition or cognition? Mechanism of change in fatigue in a randomized controlled trial of graded exercise therapy or cognitive behavior therapy for severe fatigue in patients with advanced cancer”.

Intervention

3 papers study it2 findingsUpdated

See all 3 papers on graded exercise therapy

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“No significant mediators for GET were found.”
Condition or cognition? Mechanism of change in fatigue in a randomized controlled trial of graded exercise therapy or cognitive behavior therapy for severe fatigue in patients with advanced cancerJournal of consulting and clinical psychology2021doi:10.1037/ccp0000670

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funders: KWF Kankerbestrijding and 3 more
  • Human trial2

Studies in people

2 studies gave graded exercise therapy to people and measured what changed.

What changedDesignPeopleSource

no change: Has no effect on fatigue

Randomized trial14 weeks134 peopleAdvanced cancerJournal of consulting and clinical psychology, Aug 26, 2021

no change: Has no effect on fatigue-4.7, 97.5% CI -10.2 to 0.9; P = 0.057

Randomized trial12 weeks134 peopleBothmean 63 yearsOlder adults; advanced cancer patients with severe fatigue during treatmentAnnals of oncology : official journal of the European Society for Medical Oncology, Jan 1, 2020

What did studies of graded exercise therapy find?

1

Studies of graded exercise therapy measured one outcome, fatigue.

Fatigue

no changein humans2

2 studies
  1. Graded exercise therapy showed no clear effect on fatigue in humans (advanced cancer).

    Human trialadvanced cancer14 weeks

  2. Graded exercise therapy showed no clear effect on fatigue in humans (advanced cancer patients with severe fatigue during treatment) (-4.7, 97.5% CI -10.2 to 0.9; P = 0.057).

    Human trialadvanced cancer patients with severe fatigue during treatment12 weeks

Latest